drugset / Trial / NCT03716583
Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of the present randomized double-blinded placebo-controlled clinical trial is to investigate if melatonin can protect against acute radiation dermatitis in patients with early breast cancer receiving radiation therapy, and whether this has an impact on the patients' quality of life.
Timeline
- Start
- 2019-04-30
- Primary completion
- 2021-01-31
- Completion
- 2021-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melatonin | Small molecule | 25 mg | Topical |
| Subject | dimethyl sulfoxide | Small molecule | 150 mg | Topical |